2017 U.S. POC/Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

March 2017 | 238 pages | ID: 2196A254BF3EN
Venture Planning Group

Abstracts

This new 238-page report from VPGMarketResearch contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

• Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
• Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:
• Physician Offices/Group Practices
• Emergency Rooms
• Operating/Recovery Suites
• ICUs/CCUs
• Cancer Clinics
• Ambulatory Care Centers
• Surgery Centers
• Nursing Homes
• Birth Centers

Sales and Market Share Analysis

• Sales and market shares of major hematology and flow cytometry reagent and instrument suppliers.

Instrument Placements and Installed Base

• The report provides estimates of annual placements and total installed base for major hematology and flow cytometry analyzers.

Current and Emerging Products

• Analysis of hematology and flow cytometry procedures performed in POC testing locations.
• Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

• Emerging technologies and their applications for POC testing.
• Comprehensive listings of companies developing or marketing hematology and flow cytometry testing technologies and products, by assay.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

• Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years.
• Design criteria for POC testing products.
• Alternative business expansion strategies.
• Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearchs proprietary data files.

Contains 238 pages and 38 tables

Contents

INTRODUCTION

EXECUTIVE SUMMARY

RATIONALE FOR TESTING DECENTRALIZATION
  1. OVERVIEW
  2. REGULATORY TRENDS
  3. ECONOMIC TRENDS
  4. DEMOGRAPHIC TRENDS
  5. TECHNOLOGICAL TRENDS
  6. SOCIAL TRENDS
  7. QUALITY OF CARE
  8. DEFENSIVE MEDICINE
  9. QUALITY CONTROL ISSUES

REVIEW OF CLINICAL CHEMISTRY TESTS

  1. ALBUMIN
  2. ALKALINE PHOSPHATASE
  3. ALT/SGPT
  4. AMMONIA
  5. AMYLASE
  6. AST/SGOT
  7. BILIRUBIN
  8. BLOOD GASES
  9. BLOOD UREA NITROGEN (BUN)
  10. CALCIUM
  11. CHOLESTEROL
  12. CHOLINESTERASE
  13. CREATININE
  14. ELECTROLYTES
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
  15. FERRITIN
  16. FOLLATE/FOLIC ACID
  17. FRUCTOSAMINE
  18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
  19. GLUCOSE
  20. HIGH DENSITY LIPOPROTEIN (HDL)
  21. IRON
  22. LACTATE DEHYDROGENASE (LDH)
  23. MAGNESIUM
  24. PHOSPHORUS
  25. PROTEIN
  26. TRIGLYCERIDES
  27. TROPONIN
  28. URIC ACID
  29. URINALYSIS
  30. VITAMIN B12
INSTRUMENTATION: Chemistry Analyzers Manufactured by:
  Abaxis
  Abbott
  Alfa Wassermann
  Awareness Technologies
  Beckman Coulter/Danaher
  bioMeriuex
  Carolina Chemistries
  Horiba
  Inverness
  Medica
  Nova Biomedical
  Ortho-Clinical Diagnostics
  Polimedco
  Randox
  Roche
CURRENT AND EMERGING TECHNOLOGIES
  1. MONOCLONAL ANTIBODIES
  2. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassay
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescent Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  3. DRY CHEMISTRY
  4. BIOSENSORS
  5. IT AND AUTOMATION
  6. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Strand Displacement Activation
      Self-Sustained Sequence Replicase

U.S.A.

A. Market Overview
  1. BUSINESS ENVIRONMENT
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
      PPO
      HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
      More Chronic Illness
      Disease Incidence
      Susceptibility to latrogenesis
      Multiple Illnesses Cases
    l. Laboratory Regulations
  2. MARKET STRUCTURE
    a. Hospitals
    b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
  1. MARKET SUMMARY
  2. MARKET STRUCTURE
  3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
  1. INTRODUCTION
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. EMERGENCY DEPARTMENTS
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. OPERATING AND RECOVERY SUITES
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUS/CCUS A. MARKET SUMMARY
    b. Test Volume and Sales Forecasts
D. Cancer Clinics
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS

1. MAJOR SUPPLIERS’ SALES AND MARKET SHARES

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPANY PROFILE

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
INSTRUMENTATION Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast By Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital ICUs/CCUs Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine And Special Chemistry Test Volume Forecast
U.S.A., Nursing Homes Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles, Panels and Individual Tests
U.S.A., Birth Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares